The Dallas PRP and Stem Institute is a leading orthopedic clinic where patients go to receive the latest regenerative therapies with platelet rich plasma (PRP) or stem cells for orthopedic conditions such as arthritis, back pain, tendon and ligament injuries, muscle injuries, and sports injuries. As part of its educational mission, The Institute is pleased to announce a no cost seminar series designed to inform and educate the public about the many conditions for which these treatments may be effective.
“We want patients with various orthopedic conditions to benefit from the rapidly advancing field of regenerative medicine,” said Stephanie Stephens, MD, an orthopedic surgeon at the Institute. The Institute was founded by board certified orthopedic surgeons actively involved in clinical research of regenerative biological therapies for musculoskeletal conditions. The therapies used at the Dallas PRP and Stem Cell Institute are designed to magnify and recharge the body’s own healing potential and to avoid surgery where possible. The Institute’s staff of board certified orthopedic surgeons is well qualified to inform and counsel patients on all surgical and nonsurgical options available for any orthopedic condition. “Our patients often tell us that they feel more comfortable having these procedures knowing that their doctor is a surgeon,” said Kyle Stuart, MD, one of the treating orthopedic surgeons at the institute. The seminar agenda includes lectures on the latest advances in stem cell and PRP treatment and then a Q&A session for the seminar participants.
“We have been very pleased with the growth of the Institute which is a testament to the beneficial effects that patients can receive from stem cell and PRP treatments. We can give patients another nonsurgical treatment option when clinically appropriate. For those patients who need a surgical procedure, reports show that these treatments can shorten healing times, increase surgery success, and minimize infections,” said Don Buford, MD, founder of the Dallas PRP and Stem Cell Institute. 